Vir Biotechnology, Inc.
US ˙ NasdaqGS ˙ US92764N1028

SecurityVIR / Vir Biotechnology, Inc.
InstitutionCreative Planning
Latest Disclosed Ownership100,511 shares
Latest Disclosed Value $ 900,579
Creative Planning reports 26.12% increase in ownership of VIR / Vir Biotechnology, Inc.

On May 12, 2026 - Creative Planning filed a 13F-HR form disclosing ownership of 100,511 shares of Vir Biotechnology, Inc. (US:VIR) valued at $900,579 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 79,696 shares of Vir Biotechnology, Inc.. This represents a change in shares of 26.12% during the quarter. The current value of the position is $881,481 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 100,511 20,815 26.12 901 87.50 0.0006
2026-02-17 2025-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 79,696 27,020 51.29 481 60.00 0.0003
2025-11-14 2025-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 52,676 14,917 39.51 301 57.89 0.0002
2025-08-08 2025-06-30 13F VIR BIOTECHNOLOGY COM 92764N102 37,759 25,760 214.68 190 146.75 0.0002
2025-05-15 2025-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 11,999 -2,189 -15.43 78 -25.96 0.0001
2025-02-14 2024-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 14,188 14,188 104 0.0001
2024-10-11 2024-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 0 -27,198 -100.00 0 -100.00
2024-08-15 2024-06-30 13F VIR BIOTECHNOLOGY COM 92764N102 27,198 5,385 24.69 242 10.00 0.0003
2024-05-13 2024-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 21,813 4,657 27.15 221 27.91 0.0002
2024-02-14 2023-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 17,156 17,156 173 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.